---

• n  antidiabetic consisting of any of several drugs that reduce the level of glucose in the blood; used to treat diabetes mellitus

• Combination therapy with either sulfonylurea compounds or DBI and insulin has proved uselessalso, it is anxiety-producing for both patients and physicians .
• Combination therapy with either sulfonylurea compounds or DBI and insulin has proved uselessalso, it is anxiety-producing for both patients and physicians .

News & Articles

---

• New analysis shows that patients with Type 2 diabetes and mild renal impairment had similar improvement in blood sugar ...
  ( GCI Health NY ) Merck, known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with Type 2 diabetes and mild renal impairment treated with JANUVIA (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treated with the sulfonylureas glipizide or glimepiride, with significantly fewer events of ...
  June 22, 2013 - EurekAlert!